Medicine's on the MoveWe'll keep you in the loop with stories from the forefront.

Special report: Pathology | Digital Health

David West is a proponent of digital pathology, and one of a growing band of people who believe its benefits don’t just lie in improving efficiency. By combining slide scanners with sophisticated software, the hope is that digitisation will assist pathologists in making better diagnoses of serious disease.

read more

Guest Post: AI vs MD - What it Means for Pathology

By David West, Digital Pathology Blog

Will computers replace doctors? It’s the question on everyone’s mind when reading Siddhartha Mukherjee’s article in the New Yorker “AI vs MD”, which pits human doctors against computers. It’s a beautifully composed summary on the role of software algorithms in healthcare, examining the issue through the most controversial lens.

read more

Clinical Lab Products: Product Spotlight

By Clinical Lab Products

The May 2017 issue of Clinical Lab Products, a print and online publication that acts as the product-related interface for clinical lab professionals, features Proscia in its Product Spotlight section (page 30).

read more

The Doctor's Channel: Pixels and Pathology

By The Doctor's Channel

Proscia CEO, David West Jr. discusses how digital pathology is changing cancer diagnostics and research in video interview with The Doctor’s Channel.

read more

Proscia and Huron Digital Pathology partner to provide seamlessly integrated digital pathology scanner-software solution

By Press Release

Proscia Inc., a data solutions provider for digital pathology, and Huron Digital Pathology, a provider of whole slide imaging solutions, today announced the two companies now provide seamless integration between Huron scanners and the Proscia digital pathology platform. Through this integration, pathologists will be able to quickly and easily scan slides and have them automatically uploaded to the Proscia cloud-based platform for storage, collaboration and image analysis.

read more

Proscia CEO: Digital pathology is at inflection point

By Stephanie Baum

If you were looking for some major milestone events indicating the level of interest in digital pathology, you could focus on last week when Philips acquired tumor analysis business PathXL, based in Belfast, Northern Ireland. A couple of years ago, AstraZeneca’s global biologics research and development arm, MedImmune, acquired tissue phenomics company Definiens in a $150 million deal...

read more

How newly minted Hopkins grad David West’s company is shaping the future of cancer diagnosis

By Tina Irgang

At 22, David West Jr. is already a successful entrepreneur. Inspired by his mother’s battle with breast cancer and a longstanding passion for computers, he became interested in how technology could be used to help improve diagnosis and treatment for cancer. That interest turned from an undergraduate project at Johns Hopkins University into a fast-growing digital pathology company, Proscia. Here, West discusses how Proscia got its start, and what he hopes it can do for the future of medicine...

read more

Proscia Completes $1M Seed Round of Financing to Advance Cancer Diagnosis, Treatment

By News-Medical

Proscia Inc., a data solutions provider for digital pathology, announced today the completion of its $1M seed round of financing. Proscia, whose Pathology Cloud platform is already helping hundreds of pathologists and researchers, will use the proceeds to accelerate growth and pursue the company’s vision of unlocking insights and accelerating discovery towards understanding and treating cancer...

read more

Proscia Closes $1M Seed Round, Hiring Expected

By Stephen Babcock

Two-year-old health IT startup Proscia closed a $1 million seed round, CEO David West, Jr. said Monday. The round was led by New York-based Emerald Development Managers. Also participating was TCP Venture Capital through its Propel Baltimore fund, A-Level Capital and Robin Hood Ventures. The oversubscribed round was initially targeted at $500,000, West said. The company is looking to bring digital tools to the task of diagnosing cancer.

read more

UPMC Enterprises Affiliate Selects 3 Candidates to Commercialize

By Kris Mamula

UPMC is continuing its bid for revenue diversity, taking three companies under its commercialization wing for further development. After hearing a variety of pitches from different companies Sept. 24, health system affiliate UPMC Enterprises chose Proscia Inc., Forest Devices Inc. and Podimetrics Inc. to help develop their products. The judging coincided with the annual Thrival Innovation...

read more

Meet 50 Young Entrepreneurs Aiming to Change the World

By Kerry Close

Thanks to a variety of factors, including lower startup costs and technological advances, many of the world’s most taxing problems are being tackled by some of the youngest entrepreneurs. To put this in perspective, we turned to the Kairos Society, an international organization that supports the development of entrepreneurs worldwide. Each year, the San Francisco-based company develops a list of the top global entrepreneurs under age 25.

read more

This JHU Startup Wants to Make Sure Doctors Analyze Biopsies Right - Every Time

By stephen babcock

For 150 years, the way cancer specialists looked at biopsies didn’t change much. Specialists would gather around a microscope, and analyze slides of showing tissue specimens. “That’s ridiculous,” says Johns Hopkins University biomedical engineering student David West. “There’s no way it should be done that way in 2015.” There are a couple of reasons West thinks that way...

read more

Digital Pathology and the Big “C”s (That’s “Cancer” and “Cloud”)

By Chris Mellor

Have I got cancer? 'Maybe,' says my oncologist, 'so I’m going to take a biopsy and we’ll have a look.' A small piece of my body, tissue from the potentially cancerous organ, is obtained through an incision, and sent to a pathology lab. A thin, thin slice is cut off, stained with revealing chemicals, and then checked by a pathologist. This scenario is repeated tens of million times a year around the globe, and digital health company.

read more

Baltimore Startup Takes Cancer Fight to the Cloud and Combines Machine Learning

By Dan Verel

Proscia, a Baltimore-based startup, is looking to use machine learning and cloud-based technology to combat cancer, launching a new software platform aimed at pathologists that provides storage for multi-gigabyte digital biopsies, while simultaneously harnessing what it calls 'second-opinion collaboration technology'. The cloud-based program, according to Proscia, offers large-scale management, analytics, access and collaboration for whole slide images in digital pathology, all with secure access...

read more

Proscia Introduces First Cloud-Based Platform for Digital Pathology

By Michael Batista

Founded in 2014 by technologists from Johns Hopkins, the Moffitt Cancer Center, The Ohio State University College of Medicine, and the University of Pittsburgh, Proscia is a digital healthcare company with a mission to bring image analysis and big data capabilities to pathology. Proscia’s main focus area is fighting cancer. The company’s vision is to bring computer intelligence to pathology—to organize the world’s pathology information and put it to use fighting cancer...

read more